Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

First market introduction for INOmax

Feb. 15, 2000

Synthesis and use of new PKC inhibitors in development at AstraZeneca

Feb. 15, 2000

PPL Therapeutics' transgenic AAT shows promising results in phase II

Feb. 14, 2000

Chinese university scientists design new antiallergic medications

Feb. 10, 2000

HMR contributes novel antihistaminics to Aventis pipeline

Feb. 9, 2000

Potent cell adhesion inhibitors result from Pharmacia & Upjohn/Tanabe Seiyaku collaboration

Feb. 9, 2000

Rhinocort Aqua available across U.S. for allergy relief

Feb. 9, 2000

U.S. and Scottish scientists discover novel CCR3 antagonist that inhibits eosinophil migration

Feb. 8, 2000

Antiasthmatic agent ME-3301 in clinical trials in Europe

Feb. 8, 2000

Group of selective SK channel blockers in early development at NeuroSearch

Feb. 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...